nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.297	0.632	CbGbCtD
Formoterol—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.102	0.217	CbGbCtD
Formoterol—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0438	0.0931	CbGbCtD
Formoterol—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0268	0.0571	CbGbCtD
Formoterol—Rash—Tretinoin—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Formoterol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Formoterol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Formoterol—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Formoterol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Formoterol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00041	0.000774	CcSEcCtD
Formoterol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00041	0.000773	CcSEcCtD
Formoterol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000408	0.000771	CcSEcCtD
Formoterol—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000408	0.00077	CcSEcCtD
Formoterol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000408	0.00077	CcSEcCtD
Formoterol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000408	0.000769	CcSEcCtD
Formoterol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000408	0.000769	CcSEcCtD
Formoterol—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000407	0.000768	CcSEcCtD
Formoterol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000406	0.000767	CcSEcCtD
Formoterol—Pain—Vincristine—peripheral nervous system neoplasm	0.000406	0.000767	CcSEcCtD
Formoterol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000406	0.000767	CcSEcCtD
Formoterol—Rash—Melphalan—peripheral nervous system neoplasm	0.000405	0.000764	CcSEcCtD
Formoterol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000405	0.000763	CcSEcCtD
Formoterol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000403	0.000761	CcSEcCtD
Formoterol—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000759	CcSEcCtD
Formoterol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000401	0.000758	CcSEcCtD
Formoterol—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000754	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000399	0.000753	CcSEcCtD
Formoterol—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000397	0.000749	CcSEcCtD
Formoterol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000393	0.000741	CcSEcCtD
Formoterol—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000741	CcSEcCtD
Formoterol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000392	0.000739	CcSEcCtD
Formoterol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.000739	CcSEcCtD
Formoterol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.000736	CcSEcCtD
Formoterol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.000736	CcSEcCtD
Formoterol—Nausea—Topotecan—peripheral nervous system neoplasm	0.00039	0.000735	CcSEcCtD
Formoterol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000388	0.000733	CcSEcCtD
Formoterol—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000733	CcSEcCtD
Formoterol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000386	0.000729	CcSEcCtD
Formoterol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.000729	CcSEcCtD
Formoterol—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000385	0.000726	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000383	0.000722	CcSEcCtD
Formoterol—Infection—Etoposide—peripheral nervous system neoplasm	0.000382	0.000722	CcSEcCtD
Formoterol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000382	0.00072	CcSEcCtD
Formoterol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000381	0.00072	CcSEcCtD
Formoterol—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000716	CcSEcCtD
Formoterol—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000716	CcSEcCtD
Formoterol—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000713	CcSEcCtD
Formoterol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000376	0.000709	CcSEcCtD
Formoterol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000376	0.000709	CcSEcCtD
Formoterol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000376	0.000709	CcSEcCtD
Formoterol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000375	0.000707	CcSEcCtD
Formoterol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000374	0.000706	CcSEcCtD
Formoterol—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000703	CcSEcCtD
Formoterol—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000698	CcSEcCtD
Formoterol—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000697	CcSEcCtD
Formoterol—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000689	CcSEcCtD
Formoterol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000364	0.000687	CcSEcCtD
Formoterol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000363	0.000686	CcSEcCtD
Formoterol—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000685	CcSEcCtD
Formoterol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000363	0.000685	CcSEcCtD
Formoterol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00036	0.000679	CcSEcCtD
Formoterol—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000678	CcSEcCtD
Formoterol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000359	0.000678	CcSEcCtD
Formoterol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.000668	CcSEcCtD
Formoterol—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000665	CcSEcCtD
Formoterol—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000663	CcSEcCtD
Formoterol—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000663	CcSEcCtD
Formoterol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00035	0.000661	CcSEcCtD
Formoterol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.000658	CcSEcCtD
Formoterol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000346	0.000653	CcSEcCtD
Formoterol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000343	0.000648	CcSEcCtD
Formoterol—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000646	CcSEcCtD
Formoterol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000342	0.000646	CcSEcCtD
Formoterol—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000645	CcSEcCtD
Formoterol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000341	0.000643	CcSEcCtD
Formoterol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000338	0.000638	CcSEcCtD
Formoterol—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000637	CcSEcCtD
Formoterol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.000637	CcSEcCtD
Formoterol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000335	0.000633	CcSEcCtD
Formoterol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000332	0.000627	CcSEcCtD
Formoterol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000332	0.000627	CcSEcCtD
Formoterol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000332	0.000626	CcSEcCtD
Formoterol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000329	0.000621	CcSEcCtD
Formoterol—Pain—Etoposide—peripheral nervous system neoplasm	0.000329	0.000621	CcSEcCtD
Formoterol—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000621	CcSEcCtD
Formoterol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000621	CcSEcCtD
Formoterol—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000616	CcSEcCtD
Formoterol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.000615	CcSEcCtD
Formoterol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000325	0.000614	CcSEcCtD
Formoterol—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000609	CcSEcCtD
Formoterol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000599	CcSEcCtD
Formoterol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000317	0.000599	CcSEcCtD
Formoterol—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000598	CcSEcCtD
Formoterol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000316	0.000596	CcSEcCtD
Formoterol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000315	0.000594	CcSEcCtD
Formoterol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000314	0.000593	CcSEcCtD
Formoterol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.000592	CcSEcCtD
Formoterol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.000587	CcSEcCtD
Formoterol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.000586	CcSEcCtD
Formoterol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00031	0.000584	CcSEcCtD
Formoterol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.000583	CcSEcCtD
Formoterol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000306	0.000577	CcSEcCtD
Formoterol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000575	CcSEcCtD
Formoterol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000304	0.000574	CcSEcCtD
Formoterol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000304	0.000574	CcSEcCtD
Formoterol—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000574	CcSEcCtD
Formoterol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000574	CcSEcCtD
Formoterol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000302	0.00057	CcSEcCtD
Formoterol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000301	0.000569	CcSEcCtD
Formoterol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000569	CcSEcCtD
Formoterol—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000566	CcSEcCtD
Formoterol—Rash—Vincristine—peripheral nervous system neoplasm	0.0003	0.000565	CcSEcCtD
Formoterol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000299	0.000565	CcSEcCtD
Formoterol—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000565	CcSEcCtD
Formoterol—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000563	CcSEcCtD
Formoterol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000563	CcSEcCtD
Formoterol—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000562	CcSEcCtD
Formoterol—Headache—Vincristine—peripheral nervous system neoplasm	0.000298	0.000562	CcSEcCtD
Formoterol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000554	CcSEcCtD
Formoterol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.000553	CcSEcCtD
Formoterol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000552	CcSEcCtD
Formoterol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000287	0.000543	CcSEcCtD
Formoterol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000284	0.000535	CcSEcCtD
Formoterol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000282	0.000533	CcSEcCtD
Formoterol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000532	CcSEcCtD
Formoterol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000532	CcSEcCtD
Formoterol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000526	CcSEcCtD
Formoterol—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000524	CcSEcCtD
Formoterol—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000522	CcSEcCtD
Formoterol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000276	0.000521	CcSEcCtD
Formoterol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000521	CcSEcCtD
Formoterol—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.00052	CcSEcCtD
Formoterol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000518	CcSEcCtD
Formoterol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000517	CcSEcCtD
Formoterol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000272	0.000514	CcSEcCtD
Formoterol—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000512	CcSEcCtD
Formoterol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000511	CcSEcCtD
Formoterol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000267	0.000504	CcSEcCtD
Formoterol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000502	CcSEcCtD
Formoterol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000265	0.0005	CcSEcCtD
Formoterol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000265	0.000499	CcSEcCtD
Formoterol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000499	CcSEcCtD
Formoterol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000263	0.000497	CcSEcCtD
Formoterol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000492	CcSEcCtD
Formoterol—Tension—Epirubicin—peripheral nervous system neoplasm	0.000259	0.00049	CcSEcCtD
Formoterol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000489	CcSEcCtD
Formoterol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000485	CcSEcCtD
Formoterol—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000483	CcSEcCtD
Formoterol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000254	0.00048	CcSEcCtD
Formoterol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00048	CcSEcCtD
Formoterol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000479	CcSEcCtD
Formoterol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000478	CcSEcCtD
Formoterol—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000474	CcSEcCtD
Formoterol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00025	0.000471	CcSEcCtD
Formoterol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000465	CcSEcCtD
Formoterol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000463	CcSEcCtD
Formoterol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000245	0.000462	CcSEcCtD
Formoterol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000462	CcSEcCtD
Formoterol—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000458	CcSEcCtD
Formoterol—Rash—Etoposide—peripheral nervous system neoplasm	0.000243	0.000458	CcSEcCtD
Formoterol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000242	0.000458	CcSEcCtD
Formoterol—Headache—Etoposide—peripheral nervous system neoplasm	0.000241	0.000455	CcSEcCtD
Formoterol—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000453	CcSEcCtD
Formoterol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000452	CcSEcCtD
Formoterol—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000238	0.00045	CcSEcCtD
Formoterol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000448	CcSEcCtD
Formoterol—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000447	CcSEcCtD
Formoterol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000444	CcSEcCtD
Formoterol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000441	CcSEcCtD
Formoterol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000435	CcSEcCtD
Formoterol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000229	0.000431	CcSEcCtD
Formoterol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000431	CcSEcCtD
Formoterol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000428	CcSEcCtD
Formoterol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000425	CcSEcCtD
Formoterol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000425	CcSEcCtD
Formoterol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000425	CcSEcCtD
Formoterol—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000424	CcSEcCtD
Formoterol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000423	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000422	CcSEcCtD
Formoterol—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00042	CcSEcCtD
Formoterol—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000416	CcSEcCtD
Formoterol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000415	CcSEcCtD
Formoterol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000408	CcSEcCtD
Formoterol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000407	CcSEcCtD
Formoterol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000407	CcSEcCtD
Formoterol—Infection—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000405	CcSEcCtD
Formoterol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000403	CcSEcCtD
Formoterol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000399	CcSEcCtD
Formoterol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000399	CcSEcCtD
Formoterol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000397	CcSEcCtD
Formoterol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000396	CcSEcCtD
Formoterol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000393	CcSEcCtD
Formoterol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000393	CcSEcCtD
Formoterol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000393	CcSEcCtD
Formoterol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000392	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00039	CcSEcCtD
Formoterol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000388	CcSEcCtD
Formoterol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000384	CcSEcCtD
Formoterol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00038	CcSEcCtD
Formoterol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000377	CcSEcCtD
Formoterol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000377	CcSEcCtD
Formoterol—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000374	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000371	CcSEcCtD
Formoterol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000369	CcSEcCtD
Formoterol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000368	CcSEcCtD
Formoterol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000368	CcSEcCtD
Formoterol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000366	CcSEcCtD
Formoterol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000363	CcSEcCtD
Formoterol—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000362	CcSEcCtD
Formoterol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000358	CcSEcCtD
Formoterol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000352	CcSEcCtD
Formoterol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000352	CcSEcCtD
Formoterol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000351	CcSEcCtD
Formoterol—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000348	CcSEcCtD
Formoterol—Pain—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000348	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000343	CcSEcCtD
Formoterol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000341	CcSEcCtD
Formoterol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000336	CcSEcCtD
Formoterol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000336	CcSEcCtD
Formoterol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000335	CcSEcCtD
Formoterol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000333	CcSEcCtD
Formoterol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000332	CcSEcCtD
Formoterol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000325	CcSEcCtD
Formoterol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000325	CcSEcCtD
Formoterol—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000323	CcSEcCtD
Formoterol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000322	CcSEcCtD
Formoterol—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000322	CcSEcCtD
Formoterol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000322	CcSEcCtD
Formoterol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000322	CcSEcCtD
Formoterol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00031	CcSEcCtD
Formoterol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000308	CcSEcCtD
Formoterol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000159	0.0003	CcSEcCtD
Formoterol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000299	CcSEcCtD
Formoterol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000298	CcSEcCtD
Formoterol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000298	CcSEcCtD
Formoterol—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000292	CcSEcCtD
Formoterol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000288	CcSEcCtD
Formoterol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000279	CcSEcCtD
Formoterol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000278	CcSEcCtD
Formoterol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00027	CcSEcCtD
Formoterol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000269	CcSEcCtD
Formoterol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000267	CcSEcCtD
Formoterol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000259	CcSEcCtD
Formoterol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000258	CcSEcCtD
Formoterol—Rash—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000257	CcSEcCtD
Formoterol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000256	CcSEcCtD
Formoterol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000255	CcSEcCtD
Formoterol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000249	CcSEcCtD
Formoterol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000242	CcSEcCtD
Formoterol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.00024	CcSEcCtD
Formoterol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000238	CcSEcCtD
Formoterol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000237	CcSEcCtD
Formoterol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000236	CcSEcCtD
Formoterol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000224	CcSEcCtD
